MedTrace Logo

Acute Effects of Percussion Massage Therapy in Adolescent Cyclists

NCT07206576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-12-30

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate the acute effects of percussion massage therapy (PMT) on balance, explosive strength, and functional performance in adolescent competitive cyclists aged 12-15. A total of 32 participants will be randomly assigned to either a PMT group, which will receive a single session of vibration-based therapy using a handheld percussion device (Compex Fixx 2.0), or a control group with passive rest. Performance parameters will be assessed using the Y Balance Test, vertical jump, hop tests, 10-second sprint cycling, and isometric muscle strength via dynamometry. The study seeks to determine whether PMT offers short-term neuromuscular benefits that may enhance cycling performance in youth athletes.

Conditions

  • Balanced

Interventions

DEVICE

a percussion massage gun

Participants assigned to the intervention group will receive a single session of percussion massage therapy (PMT) using the Compex® Fixx™ 2.0 handheld device. The treatment will be applied bilaterally to three major muscle groups: gluteus maximus, quadriceps femoris, and gastrocnemius. The device will operate at a high intensity setting (Level 4) with a frequency of 41.7 Hz. A wedge-shaped applicator head will be used to ensure consistent pressure across the treatment area. Each muscle group will be treated for 3 minutes, following a standardized linear stroke pattern from proximal to distal and back. The total duration of the intervention will be approximately 18 minutes. The intervention will be performed once, immediately before the post-test evaluations, and aims to assess acute effects on neuromuscular performance.

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2025-11-14
Completion
2025-11-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07206576 on ClinicalTrials.gov